Vicapsys Life Sciences, Inc. (VICP): Total Assets

Annual figures by period end, from SEC filings.

Not updated since 2023-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

$39.7K
As of 2023-12-31
$89.6K
As of 2024-09-30
-53.9%
3-year compound annual growth
$698.4K2019-12-31: $698.4K2020-12-31: $404.1K2021-12-31: $594.3K2022-12-31: $72.0K2023-12-31: $39.7K$39.7K
2019-12-31 Total Assets (USD) 2023-12-31
Period endedTotal AssetsChange YoYSource filing
2023-12-31$39.7K-44.9%2024-10-21, Balance as of period end
2022-12-31$72.0K-87.9%2024-10-21, Balance as of period end
2021-12-31$594.3K+47.1%2023-04-14, Balance as of period end
2020-12-31$404.1K-42.1%2022-03-16, Balance as of period end
2019-12-31$698.4Kn/a2021-09-17, Balance as of period end